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Endogenous signals controlling nerve cell commitment in hydra were investigated using an assay for committed 
nerve precursors. Extracts of hydra tissue were prepared and tested for their ability to induce nerve cell commitment. 
The active component in such extracts was identified as a neuropeptide, the head activator [H. C. Schaller and H. 
Bodenmiiller (1981) Proc. Natl Acad. Sk. USA 78, ‘7000-70041, based on its chromatographic properties and reaction 
with anti-head activator antibody. In addition, synthetic head activator (1O-i3-1O-n M) was shown to cause nerve cell 
commitment. Additional experiments demonstrated that committed nerve precursors require a second signal to differ- 
entiate nerve cells. Committed precursors induced by treatment of hydra with head activator do not differentiate in 
whole hydra; but do differentiate when pieces of treated tissue are explanted or when whole animals are simply injured 
with transverse cuts. The injury stimulus is long-lived. It cannot be replaced with head activator (10-‘2-10-‘0 M) but is 
contained in a methanol extract of hydra tissue. 0 1986 Academic Press. Inc. 
INTRODUCTION 
In hydra differentiation of nerve cells and nematocytes 
occurs continuously from a population of multipotent 
stem cells. These cells are uniformly distributed along 
the body column and can give rise to either nerve or 
nematocyte differentiation (for review see Bode and 
David, 1978). Commitment of stem cells to the nerve 
pathway occurs in the S phase of the stem cell cycle; 
committed cells complete the cell cycle and divide to 
yield ifferentiated n rve cells (Berking, 1979; Venugopal 
and David, 1981b; Yaross et al, 1982). 
The pattern of nerve and nematocyte differentiation 
is not uniform throughout the body column: nerve dif- 
ferentiation ccurs primarily in head and foot tissue 
whereas nematocyte differentiation occurs exclusively 
in the gastric region (David and Gierer, 1974; David and 
Challoner, 1974). Head and foot are morphogenetically 
“dominant” regions and it therefore seems likely that 
signals controlling tissue morphogenesis may also con- 
trol stem cell differentiation. 
In order to understand the nature of this control, it 
is necessary to identify the signals which cause nerve 
cell differentiation. Several years ago Schaller (1976a,b) 
initiated xperiments of this sort. Her results indicated 
that extracts of hydra tissue containing morphogenet- 
ically active substances could, under some conditions, 
enhance nerve cell differentiation during head regen- 
eration and in whole animals. The effects were generally 
small, however, for reasons which have subsequently 
become clear (see Discussion). The present experiments 
represent a continuation of Schaller’s original investi- 
gation with the benefit of better assay techniques and 
purification procedures which have recently become 
available. 
In the present experiments nerve cell commitment was 
assayed using an explantation technique in which small 
pieces of tissue were isolated from hydra and incubated 
under conditions permitting differentiation of commit- 
ted cells; uncommitted cells do not differentiate under 
these conditions (Venugopal and David, 1981a). To iden- 
tify signals causing nerve commitment, hydra were 
treated with crude extracts or partially purified xtracts 
of hydra tissue prior to assaying nerve commitment by 
the explantation procedure. 
The principal findings of the present report are that 
(1) nerve cell commitment can be induced by extracts of 
hydra tissue and (2) the active substance in extracts is 
the “head activator,” a neuropeptide which stimulates 
head differentiation n hydra (Schaller, 1973). In the 
course of these experiments we also observed that com- 
mitted nerve precursors require asecond signal to com- 
plete differentiation: nerve differentiation doesnot occur 
following treatment with hydra extracts unless the tis- 
sue is explanted. Additional experiments indicate that 
explantation can be replaced by simply injuring the tis- 
sue. The molecular nature of the injury signal is not 
known. 
MATERIALS AND METHODS 
Culture conditions and standard hydra. Hydra atten- 
uata were cultured in a modified Loomis and Lenhoff 
(1956) medium containing 1 mM CaClz, 0.1 mM MgClz, 
0.1 mM KCl, and 1 mM NaHC03 in deionized water, ad- 
justed to pH 7.8 with HCl. The culture and all the ex- 
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periments were carried out at 18 f 1°C. Cultures were 
fed daily with freshly hatched Artemia nauplii and 
washed 6-8 hr later. 
Budless hydra were used in all experiments. Animals 
were selected from the culture 22 hr after the last feed- 
ing. Such animals contain about 9000 epithelial cells and 
about 40,000 total cells. 
Identijcation of cell types by maceration. The identi- 
fication a d quantitation fcell types (David, 1973) were 
performed using a modified maceration solution (acetic 
acid:glycerin:water = 1:1:7). Ten to twenty explants were 
macerated (30-60 min, 30°C) and fixed in about 0.15 ml, 
5-10 whole animals in about 0.25 ml total volume (exact 
volume was determined by weighing); 50 ~1 of the well- 
mixed cell suspension and 2 ~1 of a 1% Tween solution 
were spread over an area of about 1 cm2 on a gelatin- 
coated microscopic slide. Counts were done using a Zeiss 
phase-contrast microscope with Plan-Neofluar objectives 
(25/O.& 40/0.‘75) on several complete passes across the 
spread and the concentration fnerve and epithelial cells 
was then calculated inthe original suspension. To com- 
pare cell numbers between samples we normalized all 
cell numbers to the number of epithelial cells (ectoder- 
ma1 and endodermal epithelial cells), which is a conve- 
nient measure of piece size. From 100 to 300 nerve cells 
and 700 to 3000 epithelial cells were counted in a given 
sample. 
Labeling with [‘Hlthymidine and au&radiography. 
Hydra were labeled with [methyZ-3H]thymidine (44Ci/ 
mmole; Amersham Buchler, Braunschweig) by injecting 
the isotope into the gastric avity using a polyethylene 
needle (David and Campbell, 1972). Animals were in- 
jected with 0.2-0.5 ~1 of the isotope solution at a con- 
centration of 25 or 50 &i/ml. Under these conditions 
essentially all injected isotope was incorporated within 
30 to 60 min. 
Gelatin-coated slides with dried macerations were 
dipped in autoradiographic emulsion (Kodak NTB 2), 
exposed 10 days at 4”C, developed in Kodak D-19 devel- 
oper (6 min at 21°C), rinsed in Ektaflo stop-bath, fixed 
in Ektaflo fixing-bath, and washed for 15 min in tap 
water. 
Assays for committed nerve precursors. Committed 
nerve precursors were assayed according to the proce- 
dure of Venugopal and David (1981a) except that ex- 
plants were incubated for 18 hr instead of 12 hr. This 
longer incubation permitted more effective r covery of 
committed precursors. To prepare explants, heads were 
removed from hydra below the tentacle ring and the 
distal fifth of the body column was excised. Such isolated 
pieces contain about 1500-1600 epithelial cells. Explants 
were maintained in closed petri dishes at a density of 
15 pieces per 10 ml of hydra medium. In all experiments 
lo-20 explants were analyzed per sample. 
In some experiments, the explantation procedure was 
replaced by injury (see Results). Animals were injured 
by three well-spaced transverse cuts per body column. 
The injured animals were maintained in closed petri 
dishes at a density of 10 animals per 10 ml of hydra 
medium; in all experiments 5-8 animals were analyzed 
per sample. 
The ratio f nerve cells to epithelial cells (Nv/Epi) in 
whole hydra is commonly 0.11-0.12; the Nv/Epi ratio in 
explants of the gastric region is commonly 0.08-0.09. 
These values form the baseline for most of the experi- 
ments reported here. However, there is some long-term 
variation in these baseline levels depending on the con- 
dition of the culture. 
Preparation of crude extract. About 1000 hydra were 
sonicated in 3 ml hydra medium under ice cooling for 
2-4 min with a Braun Labasonic 1510 ultrasonicator at 
50 W. The absorption at 280 nm was used to estimate 
the concentration fthe crude extract. An absorbance 
of 0.12 ODzeo ,,,,, corresponds to the extract of one hydra 
(without buds) per milliliter (Schaller, 1973). 
Preparation of methanol extract. Crude extract was 
prepared from about 1000 animals by sonication in 10 
ml hydra medium. After addition of 10 ml methanol, the 
extract was shaken vigorously and then centrifuged at 
5000g (6500 rpm on Sorvall SS 34 rotor) for 15 min at 
0°C. The supernatant was decanted and saved. The pellet 
was resuspended in 10 ml methanol, shaken again, and 
centrifuged at50009 for 15 min. The extraction procedure 
was repeated three times. All supernatants were com- 
bined and centrifuged again at 5000g for 15 min to re- 
move residual precipitated material. The final super- 
natant was extracted three times with 10 ml petroleum 
ether (bp 50-60°C). The methanol extract was concen- 
trated to 2 ml on a rotary evaporator and then made up 
to a final volume of 10 ml (i.e., the starting volume) and 
stored at -20°C. The concentration (hydra/ml) of the 
extract was determined from the absorbance (280 nm) 
of the initial sonicate assuming 0.12 OD28,,nm per hydra 
(Schaller, 1973). 
Hydra head activator. Hydra head activator [pGlu- 
Pro-Pro-Gly-Gly-Ser-Lys-Val-Be-Leu-Phe (Schaller 
and Bodenmtiller, 1981)] was synthesized by BACHEM 
(Switzerland). It was stabilized inits monomeric form 
by treatment with (NH4)zS04. One nanomole of the syn- 
thetic peptide was solubilized in50 ~1 distilled water, 
mixed with 50 ~13 M (NH&SO4 and thereafter with 10 
ml 1% BSA (in 0.1 M PBS, pH 7.4). This stoek solution 
was stored at -20°C in O.l-ml aliquots. Aliquots were 
thawed and diluted to the required concentration with 
hydra medium. 
Radioimmunoassay fin- hydra head activator. Ra- 
dioimmunoassays (RIA) for head activator were per- 
formed according to the method of Bodenmiiller and 
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Zachmann (1983). The incubation buffer for the RIA was 
40 mM sodium phosphate (pH 7.4) containing 2.5 mg/ 
ml bovine serum albumin, 6 mg/ml NaCl, and 1 mg/ml 
sodium azide. Peptide standards or extracts of unknown 
head activator concentration were incubated at 4°C for 
4 hr with antiserum 12.4 (l:lO,OOO) in a total volume of 
500 ~1. After 4 hr the radioactive tracer (-4000 cpm lz51- 
Tyr”-head activator) was added and incubated over- 
night. The antigen-antibody complex was precipitated 
by addition of 200 ~1 bovine y-globulin (1%) and 1.5 ml 
20% polyethylene glycol 6000 containing 0.03% Triton 
X-100 followed by centrifugation (30 min, 4’C) at 2OOOg. 
The pellets were counted in a Phillips gamma counter. 
RESULTS 
Appearance of newly diflerentiated nerve cells in ex- 
planted pieces of hydra tissue after treatment with crude 
extract. In order to identify signals inducing nerve com- 
mitment, we tested the influence of crude extract on 
whole hydra. To assay for committed nerve cells, small 
pieces of tissue were explanted from the treated animals, 
incubated for 18 hr to permit differentiation of com- 
mitted cells, and scored for nerve cells (see Materials 
and Methods). The results in Fig. 1 demonstrate an in- 
crease in the number of nerve cells (expressed as the 
ratio f nerve cells to epithelial cells: Nv/Epi) in animals 
treated with increasing amounts of crude extract. The 
maximum increase represents a doubling of the Nv/Epi 
ratio from 0.09 to 0.18 and occurs at a concentration 
corresponding to the extract of 2.0 hydra/ml. A further 
increase in the extract concentration resulted in a de- 
crease in the Nv/Epi ratio down to control evels. 























, ,,, , , , , , , , ; 
C 0.4 1.0 2.0 41) 10 
CRUDE EXTRACT Hydra/ml 
, 
20 
FIG. 1. Effect of crude extract on nerve cell differentiation. Whole 
hydra were treated with crude extract for 18 hr. Explants were pre- 
pared, incubated for 18 hr, macerated, and scored for nerve cells (NV) 
and epithelial cells (Epi). Each point represents an independent experi- 
ment. Untreated control hydra (0); crude extract-treated hydra (0). 
The change in the Nv/Epi ratio is due to a change in 
the number of nerve cells per explant since the number 
of epithelial cells remains essentially constant during 
the 18-hr incubation. Furthermore, the increase occurs 
in pieces explanted from all parts of the body column of 
treated animals (Table 1). Since such animals contain 
about 9000 epithelial cells, the total increase in newly 
differentiated n rve cells corresponds to about 800 cells 
per animal. This increase is much higher than the in- 
crease due to normal growth (David and Gierer, 1974) 
and represents differentiation of cells newly committed 
as a result of crude extract reatment. 
Identification fthe factor causing nerve commitment. 
Because it appeared likely that the active factor(s) in
the crude extract was similar to those observed previ- 
ously by Schaller (19’76b), we began our purification with 
a methanol extraction to isolate peptides and other low 
molecular weight molecules. Essentially all the biolog- 
ical activity present in crude extract was recovered in 
the methanol phase (data not shown). Figure 2 dem- 
onstrates the activity of increasing concentrations of
methanol extract in the nerve cell commitment assay. 
Maximal activity occurs at a concentration correspond- 
ing to the extract of 0.5 hydra/ml. By comparison with 
crude extract (Fig. l), methanol extract is about two 
times more active than crude extract. At present it is 
not clear whether this enhancement of the activity is 
due to removal of an inhibitor f nerve cell commitment 
during the methanol extraction rto removal of enzymes 
which destroy the active factor(s). The enhancement is 
consistently observed following methanol extraction. 
The range over which methanol extract stimulates 
nerve cell commitment is narrow: concentrations higher 
than the extract of 0.5 hydra/ml lead to a decrease in 
the ratio Nv/Epi. Thus, although methanol extract is 
significantly more active than crude extract, it still ap- 
pears to contain inhibitory and/or toxic components 
which prevent nerve cell commitment. 
In view of the fact that the head activator enhances 
nerve cell differentiation during head regeneration 
(Schaller, 1976b) and that the head activator can be ex- 
tracted with methanol, it appeared likely that at least 
one of the factors causing nerve cell commitment might 
be the head activator. To test this we attempted to re- 
move the nerve cell committing activity from methanol 
extract with procedures which remove head activator. 
1. The head activator is retained on Sep-Pak Cl8 col- 
umns (Schaller et ah, 1984). Table 2 indicates that the 
activity causing nerve cell commitment is removed by 
chromatography on Sep-Pak C18. 
2. The head activator is specifically bound by a poly- 
clonal antibody (Bodenmiiller and Zachmann, 1983). In- 
cubation of methanol extract for 24 hr with this antibody 
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TABLE 1 
EFFECT OF CRUDE EXTRACT ON NERVE CELL COMMITMENT IN 
DIFFERENT REGIONS OF THE BODY COLUMN 
Nerve cell density Increase in Nv/Epi 
Assayed region (Nv/Epi) (hs - to) 
Head 0.251 +0.06 
Upper gastric region 0.097 +0.08 
Lower gastric region 0.080 +0.07 
Peduncle/foot 0.255 +0.10 
Note. Budless hydra were treated for 18 hr with crude extract 
(1 hydra/ml). Treated animals were then cut into four sections and 
macerated directly (Q or incubated for 18 hr before maceration (&,). 
removed 90% of the activity causing nerve cell commit- 
ment (Table 2). Treatment of hydra with anti-head ac- 
tivator antibody alone had no effect on nerve cell differ- 
entiation (Table 2). 
The results above indicate that head activator or a 
closely related substance is the active component in 
methanol extract stimulating nerve commitment. 
Synthetic head activator causes nerve cell commitment. 
Recently, Schaller and Bodenmiiller (1981) determined 
the structure of the head activator. Itis an ll-amino- 
acid peptide (pGlu-Pro-Pro-Gly-Gly-Ser-Lys-Val-Ile- 
Leu-Phe) which can now be prepared synthetically. We 
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FIG. 2. Effect of methanol extract on nerve cell differentiation. Whole 
hydra were treated with methanol extract (18 hr). Following treatment 
the animals were injured (see Materials and Methods), incubated for 
18 hr, macerated, and scored for nerve cells (NV) and epithelial cells 
(Epi). Each point represents an independent experiment. Untreated 
control hydra (0); methanol extract-treated hydra (0). The lower ab- 
scissa is based on a radioimmunoassay of the head activator concen- 
tration in the methanol extract (see Materials and Methods). 
TABLE 2 
REMOVAL OF NERVE CELL COMMITTING ACTIVITY 
FROM METHANOL EXTRACTS 
Treatment Nv/Epi 
Hydra medium 0.09 
Methanol extract 0.18 
Methanol extract/Sep-Pak 0.11 
Methanol extract/anti-head activator antibody 0.10 
Anti-HA antibody 0.09 
Note. Budless hydra were treated for 18 hr as shown. Following 
treatment the animals were injured and incubated for 18 hr to induce 
differentiation fcommitted nerve precursors (see Results and Table 
4). Samples were macerated and scored for nerve and epithelial cells. 
Methanol extract: 0.5 hydra/ml. 
Methanol extract/SepPak: 20 ml methanol extract (0.5 hydra/ml) 
was applied to a Sep-Pak Cls cartridge (equilibrated with 20% meth- 
anol). Under these conditions head activator is retained by the resin 
(Schaller et aL, 1984). The eluate was used. 
Methanol extract/anti-head activator antibody: 40 ~1 of methanol 
extract (containing 0.007 pmole head activator) was added to 4 ml of 
a l/1000 dilution of anti-head activator antibody in PBS. The mixture 
was incubated overnight at 4”C, diluted l/20 to a final extract con- 
centration of 0.5 hydra/ml in hydra medium, and used directly. 
Anti-head activator antibody: Anti-head activator antibody was di- 
luted l/1000 in PBS, then diluted l/20 in hydra medium and used 
directly. 
concentrations for its ability to cause nerve cell com- 
mitment. The results in Fig. 3 indicate that head acti- 
vator at a concentration f 10-1’-10-‘3 M causes nerve 
cell commitment in our assay system. With increasing 
concentrations ofhead activator the ratio f Nv/Epi in- 
creased from a baseline value of 0.12 (untreated controls) 
to a value of 0.19. In contrast o the findings with meth- 
anol extract he head activator is active over a loo-fold 
concentration range. 
Concentration fhead activator inmethanol extracts. 
To test whether the effect of methanol extract on nerve 
cell commitment could be accounted for by head acti- 
vator, we used a radioimmunoassay to determine the 
concentration of head activator in such extracts. For 
example, the extract used for the experiments in Fig. 2 
contained a concentration f0.17 pmole/ml head acti- 
vator. Since this preparation contained the extract of 
840 hydra/ml, the amount of head activator per hydra 
is 0.2 fmole. Based on this determination a second ab- 
scissa has been added to Fig. 2 indicating the concen- 
tration of head activator in the extract. 
Comparison of the results in Figs. 2 and 3 indicates 
that methanol extract containing lo-l3 Mhead activator 
yields essentially the same level of nerve commitment 
as lo-l3 M synthetic head activator. Were additional 
factors causing nerve cell commitment present in meth- 
anol extract, then the effectiveness of methanol extract 
would be greater for a given concentration fhead ac- 
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in S phase as a result of mitogenic stimulation. This is 
certainly partially true. However, labeled nerve cells can 
\. also be induced in animals labeled with [3H]thymidine 
l ’ 
. pr&r to head activator treatment (unpublished results). 
Thus, it is clear that cells in S phase do respond to head 
activator. Furthermore, results in the accompanying re- 
port (Holstein and David, 1986) indicate that head ac- 
tivator causes commitment in S phase. 
Efect of explantation on nerve cell diflerentiation. The
“‘“I 
c 0.005 0.01 0.05 0.l 0.5 to 50 m 
marked increase in committed nerve precursors, asas- 
HEAD ACTIVATOR DM sayed by the explantation technique, after treatment 
FIG. 3. Effect of svnthetic head activator on nerve cell differentiation. 
Whole hydra were-treated with synthetic head activator (BACHEM, 
Switzerland) for 18 hr. Treated animals were injured (see Materials 
and Methods), incubated for 18 hr, macerated, and scored for nerve 
cells (NV) and epithelial cells (Epi). Each point represents an inde- 
pendent experiment. Untreated control hydra (0); head activator- 
treated hydra (0). 
tivator and thus the curve in Fig. 2 would be displaced 
to the left. Since the curves in Figs. 2 and 3 are almost 
identical when normalized to head activator content, it 
appears that head activator is the principal active com- 
ponent in methanol extract. However, the presence of 
low levels of other factors cannot be excluded given the 
errors in the measurements. 
Individual cells are committed by head activator t eat- 
ment. To test whether committed nerve precursors can 
express their committed state independent of the tissue 
in which they reside, we dissociated the tissue following 
head activator treatment and assayed the ability of sin- 
gle cells to differentiate into nerves when transferred 
to a culture system consisting of reaggregated hydra 
cells (Gierer et al., 1972). Committed nerve precursors 
have been shown to complete nerve differentiation n 
this system (Venugopal and David, 1981a; Yaross et al., 
1982). To distinguish between already existing and newly 
differentiated n rve cells, treated hydra were prelabeled 
with [3H]thymidine. The results in Table 3 indicate a
fivefold increase in the number of newly differentiated 
(labeled) nerve cells from tissue which had been treated 
for 12 hr with head activator prior to dissociation. Mix- 
ing unlabeled head activator-treated c lls with labeled 
control cells did not stimulate formation of labeled nerve 
cells from the control tissue. Hence, differentiation of 
labeled nerve cells from head activator-treated tissue is 
not simply due to the presence of head activator tissue 
in the aggregates. Rather, the result indicates that nerve 
cell commitment caused by head activator treatment is 
a cell autonomous property. 
The head activator has been shown to stimulate in- 
terstitial ce l mitoses in hydra (Schaller, 19’76a). Hence, 
the increase in labeled nerve cells observed in Table 3 
with hydra extracts leads one to expect an increase in 
newly differentiated nerve cells in whole animals treated 
with hydra extracts. However, such an increase is not 
observed. Table 4 shows that whole animals, which were 
incubated for 18 hr in methanol extract and thereafter 
for 18 hr in hydra medium, did not differentiate new
nerve cells. By comparison, explants from hydra treated 
with methanol extract showed a significant increase in 
new nerve cells. 
The surprising fact that tissue xplantation is nec- 
essary to ensure nerve cell differentiation after treat- 
ment with methanol extract raises questions about the 
nature of the signal caused by the explantation proce- 
dure. There appear to be two possible xplanations: (1) 
explantation removes an inhibitory effect emanating 
from head or foot tissue or (2) injury of the tissue during 
explantation releases a signal stimulating differentiation 
of committed precursors. These two possibilities can be 
distinguished by simply injuring tissue rather than ex- 
planting it and scoring the differentiation of committed 
nerve precursors. 
Following a standard 18-hr treatment with methanol 
extract, hydra were injured by three well-spaced trans- 
TABLE 3 
DIFFERENTIATION OF COMMITTED [‘H~HYMIDINE-LABELED 
NERVE CELLS IN REAGGREGATES 
NV*/aggregate 




61 f 10 71* 9 
17f 5 14 f 13 
9* 4 22f 9 
Note. Fifty hydra were treated for 12 hr with head activator (10-l’ 
M) or hydra medium (control), dissociated in cell culture medium, and 
reaggregated with a threefold excess of untreated hydra cells (Gierer 
et al, 1972). Each aggregate contained the equivalent of cells from one 
labeled hydra. One hour prior to dissociation treated animals were 
labeled with [‘Hlthymidine (asterisk). One group of head activator- 
treated animals was not labeled. Aggregates were macerated in groups 
of 10 after 48 and 72 hr incubation and scored for labeled nerve cells 
could be due to an increased number of interstitial ce ls (NV*) by autoradiography. 
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TABLE 4 
CHARACTERIZATION OF THE INJURY SIGNAL 
First treatment Second treatment Nv/Epi 
Hydra medium 
Methanol extract (18 hr) 
Methanol extract (18 hr) 
Methanol extract (18 hr) 
Injury (18 hr) 
Hydra medium 
Methanol extract (18 hr) 
Explant 
Hydra medium (18 hr) 
Explant (18 hr) 
Injury (18 hr) 
Explant (18 hr) 
Injury 









Methanol extract (18 hr) Methanol extract (18 hr), 
2.0 hydra/ml 
0.17 
Methanol extract (18 hr) Head activator (18 hr), 
10-i’ M 
0.12 
Methanol extract (18 hr) Head activator (18 hr), 
10-i’ M 
0.12 
Methanol extract (18 hr) Head activator (18 hr), 
10-l’ M
0.12 
First treatment: Hydra were treated with methanol extract (0.5 hy- 
dra/ml) or injured by three transverse cuts evenly spaced along the 
body column (Injury). The cuts healed in l-2 min and thereafter the 
animals were incubated in hydra medium for 18 hr. 
Second treatment: Following the first treatment animals were in- 
cubated in hydra medium, methanol extract, or head activator as 
shown. Explant: standard explants were excised from treated animals 
and incubated for 18 hr in hydra medium. Injury: see above. 
Following the second treatment, whole animals or explants were 
macerated and scored for Nv/Epi. 
verse cuts per body column. The wound closed within l- 
2 min. The animals were then incubated for 18 hr, mac- 
erated, and scored for nerve cells. Such animals exhibit 
an increase in new nerve cells which is equivalent o 
that obtained with explantation (Table 4). Figure 4 
shows quantitatively the number of cuts required to 
cause differentiation of committed nerve precursors. One 
cut placed in the middle of the body column only stim- 
ulates nerve differentiation slightly, whereas two cuts 
cause a large increase in the ratio f Nv/Epi. Additional 
cuts do not result in a further increase in the Nv/Epi 
ratio. 
Since, after injury, committed precursor cells continue 
to be exposed to signals from the head and foot, these 
signals do not inhibit he differentiation of committed 
precursor cells. Thus, the essential element in the ex- 
plantation procedure appears to be the release of a pos- 
itive signal stimulating committed precursors to com- 
plete differentiation nto nerve cells. 
To investigate he nature of the injury signal, we 
tested methanol extracts for the presence of such an 
activity. Animals were treated with methanol extract 
to induce nerve cell commitment. Thereafter animals 
were treated asecond time with varying concentrations 
of methanol extract, instead of injury, in order to induce 
differentiation of committed precursors. A small in- 
crease in nerve cells was obtained with methanol extract 
at a concentration f1.0 hydra/ml; methanol extract at 
a concentration f2 hydra/ml induced a significant in- 
crease in the Nv/Epi ratio (Table 4). This activity ap- 
pears not to be due to head activator since pure head 
activator from 10-l’ to lo-l2 M did not cause differen- 
tiation of committed precursors (Table 4). 
To investigate he lifetime of the injury stimulus, an- 
imals were injured with three cuts prior to treatment 
with methanol extract. As shown in Table 4, injury alone 
does not induce nerve cell differentiation. H wever, in- 
jury together with methanol extract or injury up to 12 
hr prior to treatment with methanol extract leads to 
differentiation of ew nerve cells (Fig. 5). However, an 
injury stimulus 24 hr prior to treatment with methanol 
extract was significantly less effective incausing differ- 
entiation fcommitted nerve precursors. Thus the injury 
stimulus appears to be long-lived. 
DISCUSSION 
Head activator causes nerve cell commitment. Our ex- 
periments how that treatment of hydra with a neuro- 
peptide, the “head activator” (Schaller and Bodenmtiller, 
1981), converts tem cells into a state such that they 
differentiate into nerve cells in explants. We define these 
cells as committed nerve precursors. The committed 
state is an autonomous property of cells ince it is ex- 
I I 1 I , 
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FIG. 4. Effect of injury on differentiation of nerve cells in hydra 
treated with methanol extract. Hydra were treated with methanol 
extract (0.5 hydra/ml; 18 hr). Transverse cuts were then made in the 
body column: single cuts were made in the middle of the body column; 
multiple cuts were evenly spaced along the body column. After incu- 
bation for 18 hr, animals were macerated and scored for nerve cells 
(NV) and epithelial cells (Epi). 
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FIG. 5. Determination of lifetime of the injury signal. Hydra were 
injured with three transverse cuts and incubated from 0 to 24 hr in 
hydra medium before addition of methanol extract (0.5 hydra/ml) for 
18 hr. At the end of extract treatment, animals were macerated and 
scored for nerve cells (NV) and epithelial cells (Epi). Abscissa: time 
(hr) between injury and addition of methanol extract. Each point rep- 
resents an independent experiment. Injured and methanol extract- 
treated hydra (0); uninjured and untreated control hydra (0). 
pressed following transplantation fsingle cells into a 
feeder layer culture system (Table 3). 
We use the term nerve commitment advisedly, since 
it implicates the idea that a multipotent cell is affected 
in its differentiation fate. Commitment appears to be 
the appropriate term in this case. Cell cloning experi- 
ments have demonstrated the presence of a multipotent 
stem cell precursor to both nerve cells and nematocytes 
in hydra (David and Murphy, 1977). No evidence for stem 
cells with limited ifferentiation potential, e.g., for nerve 
cells, was found in these experiments. Hence there is no 
evidence for the idea that committed nerve and nema- 
tocyte precursors are maintained as stable stem cell in- 
eages with limited ifferentiation p tential. However, 
the possibility that stem cells with limited self-renewal 
capacity and limited ifferentiation potential re created 
continuously inhydra cannot be excluded since such cells 
would probably not have been detected in the cloning 
experiments. 
If only multipotent stem cells exist in hydra, then in- 
creased nerve cell differentiation stimulated by head ac- 
tivator treatment must occur at the expense of these 
multipotent cells (as well as other products of these 
cells). Evidence for such a negative ffect of head acti- 
vator on stem cell self-renewal or nematocyte differ- 
entiation would be clear evidence that head activator 
interacts with uncommitted stem cells to cause nerve 
cell commitment. There is one report hat head activator 
treatment reduces nematocyte differentiation (Schaller, 
1976b) and preliminary experiments in our laboratory 
confirm this observation. These experiments also indi- 
cate that head activator treatment markedly slows the 
growth of the stem cell population in hydra (Holstein 
et aZ., in preparation). Such results are not consistent 
with the idea that head activator stimulates the differ- 
entiation of a committed precursor since in this case 
head activator t eatment would not be expected to affect 
either stem cell self-renewal ornematocyte differentia- 
tion. Hence, the evidence presently available favors the 
conclusion that head activator directly interacts with 
multipotent stem cells to cause nerve cell commitment. 
Head activator causes nerve cell commitment at a 
concentration f1O-“-1O-‘3 M (Fig. 3). Head activator 
appears to be the principal active component in hydra 
extracts ince (1) head activator accounts for most or 
all of the nerve cell committing activity in methanol 
extracts (Figs. 2 and 3) and (2) treatment of methanol 
extracts with an antibody specific for head activator re- 
moves the biological ctivity (Table 2). 
Fraction of stem cell population responding to head ac- 
tivator. The fraction of stem cells committed to nerve 
cell differentiation by head activator treatment can be 
estimated from the ratio f newly committed nerve cells 
to stem cells. Treatment with lo-l3 M head activator for 
18 hr causes amaximum increase of about 300 committed 
nerve precursors per animal (0.07 Nv/Epi X 9000 Epi/ 
animal X 1 precursor/2 nerve cells). Such animals have 
about 3000 large interstitial ce ls (1s + 2s; data not 
shown) of which about 1200 are stem cells (David and 
Gierer, 1974). Assuming that commitment occurs at a 
unique point in the cell cycle (Berking, 1979; Venugopal 
and David, 1981c; Yaross et al., 1982) and that the stem 
cell cycle is 24-27 hr (Campbell and David, 1974), the 
results indicate that -25% of all available stem cells 
are committed to nerve precursors in treated animals. 
Since the same level of committed nerve precursors is 
also achieved after only 12 hr of treatment (Holstein 
and David, 1986), this value of 25% is an underestimate. 
A more realistic estimate would appear to be -40% of 
available stem cells. This rate is extraordinarily high 
compared to the 7.0% stem cells which are committed 
to nerve differentiation during an 18-hr period in normal 
untreated animals (David and Gierer, 1974). 
It is interesting toestimate the number of head ac- 
tivator molecules which are required to cause nerve cell 
commitment. Under our standard assay conditions 10 
animals (40,000 total cells per hydra of which about 1200 
are stem cells; ee above) are incubated for 18 hr in lo-l3 
M head activator (corresponding to6 X lo* molecules 
per assay). If all cells bind head activator and all the 
head activator isbound during the incubation, then each 
cell would bind 1500 head activator molecules. If only 
stem cells bind head activator, then each stem cell would 
bind 50,000 molecules. Such estimates are of necessity 
approximate since at present we have no information 
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about the number, localization, r binding properties of 
head activator eceptors. However, they suggest that 
relatively few molecules are likely to be sufficient to
cause nerve cell commitment. 
Assuming that head activator is the principal signal 
regulating nerve cell commitment in z)ivo, itis possible 
to estimate the in viva distribution ffree (active) head 
activator from the pattern of nerve cell commitment in 
whole animals (Venugopal and David, 1981c). This pat- 
tern of nerve cell commitment has high levels at both 
head and foot ends and relatively ow levels throughout 
most of the body column. The transition from high levels 
at the ends to low levels in the body column appears to 
be quite sharp and is best described as a step. While the 
high levels in the head are easily understood as local 
high levels of free head activator, itseems likely that 
the high levels in the foot are due to another molecule, 
the foot activator (Grimmelikhuijzen and Schaller, 
1977). It is interesting tonote that the concentration 
profile ofhead activator along the body column inferred 
from the pattern of nerve cell commitment is very sim- 
ilar to the pattern of head “activation” postulated by 
MacWilliams’ (1982) model of hydra morphogenesis. 
Committed nerve precursors require a second signal to 
diaerentiate. A surprising result of the present study 
was that the differentiation of committed nerve precur- 
sors occurred only in explants or in animals which were 
injured after treatment with extracts (Table 4). Differ- 
entiation of nerve cells did not occur in hydra treated 
with extract but not injured or in hydra which were 
injured but not treated with extract. Further results 
discussed in the accompanying paper (Holstein and 
David, 1986) indicate that committed nerve precursors 
are blocked in Gl phase of the cell cycle. Injury or ex- 
plantation relieves this block. 
The nature of the injury stimulus is at present unclear. 
It does not appear to be due to depletion of differentiation 
inhibitors atthe site of wounding since it is a long-lived 
effect whereas wounds close rapidly. In particular in- 
hibitory molecules emanating from head and foot tissue, 
which are known to leak at cut surfaces (Kemmner and 
Schaller, 1984), would be rapidly replenished after the 
wound heals. Thus it appears more likely that injury 
causes the release of a stimulatory signal into the tissue. 
This signal appears to be present in methanol extracts 
(Table 4). Since the head activator is known to be re- 
leased at cut surfaces (Schaller, 1976c), it seemed pos- 
sible that the injury stimulus was head activator. How- 
ever, head activator cannot replace the injury stimulus 
at any concentration from 10-l’ to 10-l’ M (Table 4). 
Furthermore, the injury stimulus itself does not lead to 
commitment of nerve precursors (Table 4) as would be 
expected if significant amounts of head activator were 
released at the site of injury. Thus, it does not appear 
likely that the injury stimulus is due to the local release 
of head activator. The molecular nature of the injury 
signal is presently unknown. However, it is interesting 
to note that treatment of hydra with 10e5 M dibutyryl 
cyclic AMP and 10e3 M theophylline can mimic the injury 
stimulus (unpublished observations). 
The most intriguing aspect of the injury stimulus is 
the possibility that it may be an experimental procedure 
which mimics a normal control mechanism. Several 
years ago Berking (1980) demonstrated the presence of 
committed nerve precursors inthe budding region. These 
cells migrate to the site of the prospective bud prior to 
bud evagination. Five hours after the start of evagina- 
tion they differentiate synchronously into nerve cells. 
Thus, the signal initiating bud evagination is similar, 
in its effect on nerve differentiation, t  the injury stim- 
ulus Perhaps they are the same signal. 
Were the budding signal and the injury signal iden- 
tical, then the budding signal should also be long-lived 
and buds should not exhibit he block to nerve differ- 
entiation which is characteristic of adult tissue. This is 
actually true. Head activator treatment of very young 
buds, i.e., buds which were collected within 12 hr after 
detaching from the mother animal, causes nerve cell dif- 
ferentiation without an injury stimulus (data not 
shown). By the time buds are l-2 days old this property 
disappears and injury is required to obtain differentia- 
tion of committed nerve precursors. This fact also pro- 
vides an explanation for Schaller’s (1976b) observation 
of enhanced nerve differentiation f llowing head acti- 
vator treatment in animals which were not injured. Since 
Schaller used young buds for her experiments, her ob- 
servations are in accord with our results. 
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